Portfolio of Diabetes Stocks

Here is a sample of 12 stocks that provide diabetes treatments and monitoring.


12 Diabetes Stocks

Name
& Monthly Returns

Symbol
& Snapshot

Recent Prices
& Trendline Chart

Abbott LaboratoriesABT
AstraZenecaAZN
DexComDXCM
Eli LillyLLY
Insulet CorporationPODD
Lexicon PharmaceuticalsLXRX
MannKind Corp.MNKD
MedtronicMDT
Novo NordiskNVO
Provention BioPRVB
Senseonics HoldingsSENS
Tandem Diabetes CareTNDM
Sparkline weekly price charts based on Alpha Vantage data.


Portfolio Values

To inspect the performance of the Diabetes Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 11 stocks included in the portfolio computations are: ABT, AZN, DXCM, LLY, PODD, LXRX, MNKD, MDT, NVO, SENS and TNDM. The current value of the portfolio assumes that $909.09 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. PRVB was excluded from the portfolio computations because of insufficient price data.

The current value of the $10,000 investment is $29,982. The percent return is 199.82%. The annualized return is 24.56%.



Portfolio Value Chart for Last 100 Daily Closes


Values of User-Selected Sample Portfolios: Discover the Most and Least Profitable Sample Portfolios



Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Dividend-Paying Pharmaceutical Stocks